Francisco Rodriguez

Francisco Rodriguez, Ph.D., currently serves as Associate Director Clinical Scientist in Oncology at Daiichi Sankyo, Inc. since February 2024. Prior experience includes roles as Clinical Scientist in Oncology at ICON plc, contributing to the Merck embedded program, and as Medical Scientist in Late Stage Development Oncology at AstraZeneca. Francisco began a career in clinical research at Vanderbilt University Medical Center, where significant contributions were made as a Clinical Trials Specialist in Hematology-Oncology, as well as a Graduate Student Researcher and Teaching Assistant focused on protein biochemistry. The educational background includes a Ph.D. in Chemistry from Vanderbilt University and a Bachelor of Science in Biochemistry from California State University, Long Beach. Prior research experience includes a position as a Research Assistant at VA Long Beach, and research efforts have centered around the activation mechanisms of critical proteins relevant to medicine.